A clinical study showed that CD56dimCD16− and CD56brightCD16− NK cells represent the predominant NK cell subpopulations in acute myeloid leukemia (AML) and that CD39+/CD38+ cells cluster on CD56brightCD16− NK cells. The gene discussed is CD38; the disease is acute myeloid leukemia.